Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Conjupro Biotherapeutics, Inc.
National Institutes of Health Clinical Center (CC)
Filamon LTD
Ensem Therapeutics
Atavistik Bio, Inc
Ataturk University
PMV Pharmaceuticals, Inc
AstraZeneca
NiKang Therapeutics, Inc.
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
Alterome Therapeutics, Inc.
Hoffmann-La Roche
Rutgers, The State University of New Jersey
Eli Lilly and Company
AstraZeneca
BeOne Medicines
National Institutes of Health Clinical Center (CC)
University College Cork
University of California, Davis
Bayer
Genmab
Genmab
Psyence Australia Pty Ltd
Convalife (Shanghai) Co., Ltd.
University of California, Irvine
Eastern Cooperative Oncology Group
Eli Lilly and Company
ViroMissile, Inc.
Terremoto Biosciences Inc.
Dana-Farber Cancer Institute
Jazz Pharmaceuticals
Kaiser Permanente
Duke University
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
University of Florida
Essen Biotech
Essen Biotech
AstraZeneca
Clasp Therapeutics, Inc.
Karolinska Institutet
Memorial Sloan Kettering Cancer Center
Incyte Corporation